Chesapeake Wealth Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.17M | Sell |
3,334
-85
| -2% | -$30.3K | 0.36% | 68 |
|
|
2025
Q4 | $1.12M | Sell |
3,419
-24
| -0.7% | -$7.61K | 0.33% | 74 |
|
|
2025
Q3 | $972K | Buy |
3,443
+19
| +0.6% | +$5.51K | 0.3% | 78 |
|
|
2025
Q2 | $956K | Sell |
3,424
-20
| -0.6% | -$5.67K | 0.32% | 77 |
|
|
2025
Q1 | $1.07M | Sell |
3,444
-186
| -5% | -$54.9K | 0.38% | 67 |
|
|
2024
Q4 | $946K | Sell |
3,630
-69
| -2% | -$20.5K | 0.32% | 78 |
|
|
2024
Q3 | $1.19M | Sell |
3,699
-17
| -0.5% | -$5.56K | 0.41% | 63 |
|
|
2024
Q2 | $1.16M | Sell |
3,716
-177
| -5% | -$52K | 0.42% | 64 |
|
|
2024
Q1 | $1.11M | Sell |
3,893
-125
| -3% | -$36.6K | 0.4% | 67 |
|
|
2023
Q4 | $1.16M | Sell |
4,018
-55
| -1% | -$15K | 0.45% | 65 |
|
|
2023
Q3 | $1.09M | Sell |
4,073
-102
| -2% | -$25.5K | 0.46% | 65 |
|
|
2023
Q2 | $927K | Sell |
4,175
-75
| -2% | -$17.4K | 0.37% | 76 |
|
|
2023
Q1 | $1.03M | Sell |
4,250
-37
| -0.9% | -$9.08K | 0.43% | 71 |
|
|
2022
Q4 | $1.13M | Hold |
4,287
| – | – | 0.49% | 61 |
|
|
2022
Q3 | $966K | Sell |
4,287
-51
| -1% | -$12.4K | 0.44% | 63 |
|
|
2022
Q2 | $1.05M | Sell |
4,338
-34
| -0.8% | -$8.33K | 0.45% | 62 |
|
|
2022
Q1 | $1.06M | Sell |
4,372
-134
| -3% | -$30.8K | 0.38% | 68 |
|
|
2021
Q4 | $1.01M | Sell |
4,506
-360
| -7% | -$76K | 0.34% | 75 |
|
|
2021
Q3 | $1.03M | Sell |
4,866
-1,310
| -21% | -$302K | 0.37% | 66 |
|
|
2021
Q2 | $1.51M | Sell |
6,176
-441
| -7% | -$108K | 0.49% | 50 |
|
|
2021
Q1 | $1.65M | Sell |
6,617
-253
| -4% | -$60.4K | 0.55% | 42 |
|
|
2020
Q4 | $1.58M | Sell |
6,870
-158
| -2% | -$36.4K | 0.54% | 47 |
|
|
2020
Q3 | $1.79M | Sell |
7,028
-57
| -0.8% | -$14.1K | 0.67% | 34 |
|
|
2020
Q2 | $1.67M | Sell |
7,085
-4
| -0.1% | -$913 | 0.66% | 33 |
|
|
2020
Q1 | $1.44M | Buy |
7,089
+773
| +12% | +$169K | 0.66% | 34 |
|
|
2019
Q4 | $1.52M | Sell |
6,316
-40
| -0.6% | -$8.82K | 0.59% | 44 |
|
|
2019
Q3 | $1.23M | Buy |
6,356
+12
| +0.2% | +$2.3K | 0.5% | 58 |
|
|
2019
Q2 | $1.17M | Sell |
6,344
-2,293
| -27% | -$411K | 0.49% | 57 |
|
|
2019
Q1 | $1.64M | Buy |
8,637
+543
| +7% | +$104K | 0.72% | 35 |
|
|
2018
Q4 | $1.58M | Buy |
8,094
+1,573
| +24% | +$307K | 0.78% | 28 |
|
|
2018
Q3 | $1.35M | Sell |
6,521
-115
| -2% | -$22.7K | 0.6% | 43 |
|
|
2018
Q2 | $1.23M | Sell |
6,636
-142
| -2% | -$25.1K | 0.57% | 51 |
|
|
2018
Q1 | $1.16M | Buy |
+6,778
| New | +$1.24M | 0.53% | 53 |
|
Other funds holding AMGN
VCM
VPM
Chesapeake Wealth Management's AMGN Position: Q1 2026 in Review
Chesapeake Wealth Management reduced its Amgen (AMGN) stake by 2.5% in Q1 2026, selling an estimated $30.3K and leaving 3,334 shares worth $1.17M. The position accounts for 0.36% of the portfolio, ranked #68.
Chesapeake Wealth Management first reported a position in AMGN in Q1 2018 and has held it in 33 quarters since. The position peaked at $1.79M in Q3 2020. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Chesapeake Wealth Management held 3,334 shares of Amgen worth $1.17M as of Q1 2026.
- Chesapeake Wealth Management sold 85 Amgen shares in Q1 2026, an estimated $30.3K.
- Amgen made up 0.36% of Chesapeake Wealth Management's portfolio in Q1 2026, its #68 holding.
- Chesapeake Wealth Management first reported a position in Amgen in Q1 2018 and has held it in 33 quarters since.
- Chesapeake Wealth Management's Amgen position peaked at $1.79M in Q3 2020.
- 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Chesapeake Wealth Management's 13F filing for Q1 2026, filed 18 May 2026.